Sign up to save your podcasts
Or
Share Gene Editing: The Future of Genomic Medicine & Biotech Investing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gene Editing: The Future of Genomic Medicine & Biotech Investing
In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new innovations in gene editing are transforming the future of medicine and the greater biotech investment landscape.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
906906 ratings
In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new innovations in gene editing are transforming the future of medicine and the greater biotech investment landscape.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Exchanges
View all
Bloomberg Surveillance
1,200 Listeners
Bloomberg Intelligence
402 Listeners
Notes on the Week Ahead
189 Listeners
Insights Now
94 Listeners
Masters in Business
2,174 Listeners
Odd Lots
1,789 Listeners
Capital Allocators – Inside the Institutional Investment Industry
804 Listeners
Wall Street Breakfast
1,029 Listeners
UBS On-Air: Market Moves
181 Listeners
Making Sense
58 Listeners
Thoughts on the Market
1,267 Listeners
At Any Rate
80 Listeners
The Memo by Howard Marks
416 Listeners
Global Data Pod
24 Listeners
The Markets
70 Listeners